Reciprocity agreement between ESVB and SOLACI

On behalf of all who make part of SOLACI, we are thrilled to announce a reciprocity and mutual collaboration agreement with the European Symposium of Vascular Biomaterials (ESVB). This association will allow us to create new relationships with important European professionals in the field and, in time, enhance and strengthen the presence of SOLACI worldwide. 

esvb_2017_02_october_12-14-2017-bis

This year, the ESVB celebrates the tenth edition of their annual symposium, which will take place on October 12 to 14, 2017, in Strasburg, France. This event is a great opportunity to meet renowned scientists and researchers from all over the world involved in the study and usability of vascular and endovascular biomaterials.

 

The main topics will be:

  • Vascular and endovascular device durability.
  • The latest trends in pre-surgery imaging technology.
  • Tissue, plaque and vascular wall properties and endovascular technologies.
  • Updates on state of the art endovascular technology by experts.

 

You may see the preliminary program or obtain more information on the Congress .

 

We will soon publish more information.

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...